Vaccinations are now available to protect against chikungunya virus (CHIKV) infections; however, the overall potential to reduce the burden of this mosquito-transmitted disease remains uncertain.
Currently, approximately 2.8 billion people live in areas at risk, and the virus infects an estimated 35 million individuals annually.
Will Travelers Embrace Chikungunya Vaccines
Germany Expands Travel Vaccine Access
With international travel expected to accelerate over the next few years, more Germans will soon have access to innovative travel vaccines based on a new distribution agreement.
Valneva SE announced today an exclusive three-year agreement with CSL Seqirus for the marketing and distribution of Valneva’s three proprietary vaccines in Germany.